Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group study

W. Friedenberg,Janet W. Anderson,B. Wolf,P. Cassileth,M. Oken
DOI: https://doi.org/10.1002/1097-0142(19930515)71:10<2983::AID-CNCR2820711016>3.0.CO;2-1
IF: 6.9209
1993-05-15
Cancer
Abstract:Background. Thirty‐six patients with relapsing or refractory chronic lymphocytic leukemia were entered into a Phase II study of the Eastern Cooperative Oncology Group.
What problem does this paper attempt to address?